Nexalin Technology (NXL) Enterprise Value (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Enterprise Value of -$2.7 million for Q1 2026, down 32.05% year-over-year from -$4.0 million in Q1 2025, and up 55.87% quarter-over-quarter from -$6.1 million in Q4 2025.
Nexalin Technology (NXL) Enterprise Value (2021 - 2026) Analysis & Trends
Nexalin Technology's Enterprise Value history runs 6 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 32.05% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$2.7 million (down 32.05% YoY), while the FY2025 annual figure was -$6.1 million, down 76.35% from the prior year.
- Enterprise Value for Q1 2026 stood at -$2.7 million, up from -$6.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$848796.0 in Q2 2024, with the low at -$10.6 million in Q1 2023.
- The 5-year median for Enterprise Value is -$5.8 million (2025), against an average of -$5.5 million.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value tumbled 956.84% in 2022, then surged 90.49% in 2024.
- Nexalin Technology's Enterprise Value stood at -$7.0 million in 2022, then surged by 57.84% to -$2.9 million in 2023, then decreased by 18.03% to -$3.5 million in 2024, then tumbled by 76.35% to -$6.1 million in 2025, then soared by 55.87% to -$2.7 million in 2026.
- Business Quant data shows NXL's Enterprise Value at -$2.7 million in Q1 2026, -$6.1 million in Q4 2025, and -$4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Nexalin Technology | 7.01 Mn | 6.00 Mn | 8,897.00 | -1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 Mn |
| Mar 31, 2026 | -2.71 Mn |
| Dec 31, 2025 | -6.14 Mn |
| Sep 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -5.79 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | -3.48 Mn |
| Sep 30, 2024 | -9.02 Mn |
| Jun 30, 2024 | -848,796.00 |
| Mar 31, 2024 | -3.20 Mn |
| Dec 31, 2023 | -2.95 Mn |
| Sep 30, 2023 | -7.15 Mn |
| Jun 30, 2023 | -8.93 Mn |
| Mar 31, 2023 | -10.60 Mn |
| Dec 31, 2022 | -6.99 Mn |
| Sep 30, 2022 | -7.86 Mn |
| Dec 31, 2021 | -661,778.00 |